|
VPRBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.184300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.201900E-04 |
| Normal-vs-Stage2 |
3.817500E-02 |
| Normal-vs-Stage3 |
4.916900E-03 |
| Normal-vs-Stage4 |
1.00599999997009E-06 |
| Stage1-vs-Stage2 |
8.851400E-01 |
| Stage1-vs-Stage3 |
4.515600E-01 |
| Stage1-vs-Stage4 |
8.501600E-02 |
| Stage2-vs-Stage3 |
6.581000E-01 |
| Stage2-vs-Stage4 |
1.093250E-01 |
| Stage3-vs-Stage4 |
2.299400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.982900E-04 |
| Normal-vs-AfricanAmerican |
4.600600E-04 |
| Normal-vs-Asian |
3.255600E-03 |
| Caucasian-vs-AfricanAmerican |
5.410800E-01 |
| Caucasian-vs-Asian |
4.871800E-01 |
| AfricanAmerican-vs-Asian |
5.612000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7339699999952E-05 |
| Normal-vs-Female |
3.505600E-01 |
| Male-vs-Female |
8.142900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.597300E-04 |
| Normal-vs-Extreme_Weight |
1.041840E-04 |
| Normal-vs-Obese |
1.965740E-02 |
| Normal-vs-Extreme_Obese |
1.202440E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.736400E-01 |
| Normal_Weight-vs-Obese |
1.379390E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.936600E-01 |
| Extreme_Weight-vs-Obese |
1.611970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.808000E-01 |
| Obese-vs-Extreme_Obese |
5.508200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.513760E-01 |
| Normal-vs-Age(41-60Yrs) |
1.245780E-02 |
| Normal-vs-Age(61-80Yrs) |
4.14389999999765E-05 |
| Normal-vs-Age(81-100Yrs) |
4.19280000000244E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.307000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.809600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.661600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.525630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.242210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.121600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.540500E-03 |
| Normal-VS-Type2 PRCC |
2.42589999999154E-06 |
| Normal-VS-KIRP CIMP |
4.072600E-01 |
| Normal-VS-Unclassified PRCC |
1.820990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.773610E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.174400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.177200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.620190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.191700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.074000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.98030000029415E-07 |
| Normal-vs-N1 |
3.681500E-03 |
| Normal-vs-N2 |
2.741000E-03 |
| N0-vs-N1 |
4.261600E-01 |
| N0-vs-N2 |
7.731200E-01 |
| N1-vs-N2 |
5.149600E-01 |
|
|
